[CHRS] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
08-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 16.82%
YoY- 35.37%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 110,419 123,856 0 0 844 10,198 6,493 60.29%
PBT 10,760 41,271 -62,596 -49,069 -75,944 -52,580 -29,023 -
Tax 1,052 2,044 70 114 428 489 155 37.55%
NP 9,708 39,227 -62,596 -49,067 -75,921 -52,391 -29,134 -
Tax Rate -9.78% -4.95% - - - - - -
Total Cost 100,711 84,629 62,596 49,067 76,765 62,589 35,627 18.89%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 8.79 31.67 0.00 0.00 -8,995.38 -513.74 -448.70 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 0.13 0.56 -0.92 -0.84 -1.71 -1.35 -1.47 -
EPS Diluted 0.12 0.53 -0.92 -0.84 -1.71 -1.35 -1.47 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.